Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Arnold & Porter
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Duane Morris LLP
With the advancements in technology and the advent of artificial intelligence, the medical device industry is flourishing.
Duane Morris LLP
The FCA creates liability for persons or entities found to have knowingly submitted false claims to the government or having caused others to do so.
Wilson Sonsini Goodrich & Rosati
The U.S. Food and Drug Administration (FDA) continues advancing regulatory policies tailored to the digital health community. On September 26, 2019
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released a series of guidance documents addressing the agency's ...
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released the draft guidance entitled "Clinical Decision Support Software" (CDS guidance), ...
Duane Morris LLP
Genetic testing and telemedicine targeting senior citizens and individuals with disabilities have been the subject of growing government scrutiny.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Reed Smith
Today's guest post is by Reed Smith‘s Jenn Eppensteiner. In it she discusses a recurring theme on the Blog – claimed product "defects" arising from nothing more than the failure of an implanted ...
Reed Smith
The defense has done a good job of preventing class certification of drug and device mass torts. Individual issues of usage, causation, reliance, injury, etc. predominate over alleged common issues.
Shook, Hardy & Bacon L.L.P.
Shook Partners Hildy Sastre and Jennise Stubbs, along with Of Counsel Sonali Gunawardhana, have co-authored the USA section of Chambers and Partners'
Ropes & Gray LLP
In this recap of our September presentation, which includes video and an accompanying transcript, panelists – life sciences regulatory & compliance partner Kellie Combs,...
BakerHostetler
Acting FDA Commissioner Discusses Food Safety Modernization Act (FSMA) Progress – Acting Commissioner Sharpless announced the Food ...
Sheppard Mullin Richter & Hampton
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement...
Shook, Hardy & Bacon L.L.P.
Shook Partner Chris Kaufman and Associate Torrey Peterson have co-authored an article for DRI's For the Defense on "Exposing Meritless Claims in Drug and Medical Device Product Liability MDLs."
Reed Smith
Recently, Bexis was contacted by a reporter who had read the blog's post on ghostwriting. Bexis explained that people at the top of any profession
Wilson Sonsini Goodrich & Rosati
In 2018, the administration published its Blueprint to Lower Drug Prices for U.S. citizens.
Cooley LLP
Health regulatory news and issues.
Hogan Lovells
On 26 September 2019 the U.S. Food and Drug Administration (FDA or the agency) published a draft guidance document entitled "Providing Regulatory Submissions for Medical Devices
Latest Video
Most Popular Recent Articles
Oblon, McClelland, Maier & Neustadt, L.L.P
Design patents are very different from utility patents in that design patents only protect the ornamental features of an invention. In contrast to utility patents, the design is defined
Sheppard Mullin Richter & Hampton
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement...
Shook, Hardy & Bacon L.L.P.
Plaintiffs' attorneys are spending billions of dollars saturating the airwaves with advertisements that target prescription drugs and medical devices for lawsuits.
Marshall, Gerstein & Borun LLP
What is synthetic biology? At a fundamental level, synthetic biology is an interdisciplinary area applying engineering principles to biology ...
Arnold & Porter
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
Morrison & Foerster LLP
We are pleased to announce the launch of the MoFo NDCal IP Resource Center. This complimentary resource is available to the public and provides insights on the judges
Oblon, McClelland, Maier & Neustadt, L.L.P
The majority expressed caution about the breadth of its holding, in particular about concerns that the holding could harm the nascent field of personalized medicine.
Akin Gump Strauss Hauer & Feld LLP
In this episode, Akin Gump health care and life sciences counsel Taylor Jones and Matt Wetzel discuss the Justice Department's recent guidance on evaluation of corporate compliance programs.
Reed Smith
Today's guest post is by Reed Smith‘s Jenn Eppensteiner. In it she discusses a recurring theme on the Blog – claimed product "defects" arising from nothing more than the failure of an implanted ...
Reed Smith
Few things raise our blood pressure as much as the MDL process. MDL stands for Multi-District Litigation, but the M might as well stand for Mutilating and the D for Distorting.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with